Caseware UK (AP4) 2024.0.164 2024.0.164 2025-03-312025-03-312025-03-3174false2024-04-01false73falsefalse 03934865 2024-04-01 2025-03-31 03934865 2023-04-01 2024-03-31 03934865 2025-03-31 03934865 2024-03-31 03934865 2023-04-01 03934865 2 2023-04-01 2024-03-31 03934865 3 2023-04-01 2024-03-31 03934865 d:CompanySecretary1 2024-04-01 2025-03-31 03934865 d:Director1 2024-04-01 2025-03-31 03934865 d:Director2 2024-04-01 2025-03-31 03934865 d:Director3 2024-04-01 2025-03-31 03934865 d:Director4 2024-04-01 2025-03-31 03934865 d:Director5 2024-04-01 2025-03-31 03934865 d:RegisteredOffice 2024-04-01 2025-03-31 03934865 e:Buildings 2024-04-01 2025-03-31 03934865 e:Buildings 2025-03-31 03934865 e:Buildings 2024-03-31 03934865 e:Buildings e:OwnedOrFreeholdAssets 2024-04-01 2025-03-31 03934865 e:MotorVehicles 2024-04-01 2025-03-31 03934865 e:MotorVehicles 2025-03-31 03934865 e:MotorVehicles 2024-03-31 03934865 e:MotorVehicles e:OwnedOrFreeholdAssets 2024-04-01 2025-03-31 03934865 e:ComputerEquipment 2024-04-01 2025-03-31 03934865 e:ComputerEquipment 2025-03-31 03934865 e:ComputerEquipment 2024-03-31 03934865 e:ComputerEquipment e:OwnedOrFreeholdAssets 2024-04-01 2025-03-31 03934865 e:OtherPropertyPlantEquipment 2024-04-01 2025-03-31 03934865 e:OtherPropertyPlantEquipment 2025-03-31 03934865 e:OtherPropertyPlantEquipment 2024-03-31 03934865 e:OtherPropertyPlantEquipment e:OwnedOrFreeholdAssets 2024-04-01 2025-03-31 03934865 e:OwnedOrFreeholdAssets 2024-04-01 2025-03-31 03934865 e:CurrentFinancialInstruments 2025-03-31 03934865 e:CurrentFinancialInstruments 2024-03-31 03934865 e:Non-currentFinancialInstruments 2025-03-31 03934865 e:Non-currentFinancialInstruments 2024-03-31 03934865 e:CurrentFinancialInstruments e:WithinOneYear 2025-03-31 03934865 e:CurrentFinancialInstruments e:WithinOneYear 2024-03-31 03934865 e:Non-currentFinancialInstruments e:AfterOneYear 2025-03-31 03934865 e:Non-currentFinancialInstruments e:AfterOneYear 2024-03-31 03934865 e:Non-currentFinancialInstruments e:BetweenOneTwoYears 2025-03-31 03934865 e:Non-currentFinancialInstruments e:BetweenOneTwoYears 2024-03-31 03934865 e:Non-currentFinancialInstruments e:BetweenTwoFiveYears 2025-03-31 03934865 e:Non-currentFinancialInstruments e:BetweenTwoFiveYears 2024-03-31 03934865 e:ShareCapital 2025-03-31 03934865 e:ShareCapital 2024-03-31 03934865 e:ShareCapital 2023-04-01 03934865 e:RevaluationReserve 2024-04-01 2025-03-31 03934865 e:InvestmentPropertiesRevaluationReserve 2025-03-31 03934865 e:InvestmentPropertiesRevaluationReserve 2024-03-31 03934865 e:InvestmentPropertiesRevaluationReserve 2023-04-01 03934865 e:InvestmentPropertiesRevaluationReserve 2 2023-04-01 2024-03-31 03934865 e:InvestmentPropertiesRevaluationReserve 3 2023-04-01 2024-03-31 03934865 e:RetainedEarningsAccumulatedLosses 2024-04-01 2025-03-31 03934865 e:RetainedEarningsAccumulatedLosses 2025-03-31 03934865 e:RetainedEarningsAccumulatedLosses 2023-04-01 2024-03-31 03934865 e:RetainedEarningsAccumulatedLosses 2024-03-31 03934865 e:RetainedEarningsAccumulatedLosses 2023-04-01 03934865 e:RetainedEarningsAccumulatedLosses 2 2023-04-01 2024-03-31 03934865 e:RetainedEarningsAccumulatedLosses 3 2023-04-01 2024-03-31 03934865 e:AcceleratedTaxDepreciationDeferredTax 2025-03-31 03934865 e:AcceleratedTaxDepreciationDeferredTax 2024-03-31 03934865 e:OtherDeferredTax 2025-03-31 03934865 e:OtherDeferredTax 2024-03-31 03934865 d:OrdinaryShareClass1 2024-04-01 2025-03-31 03934865 d:OrdinaryShareClass1 2025-03-31 03934865 d:OrdinaryShareClass1 2024-03-31 03934865 d:OrdinaryShareClass2 2024-04-01 2025-03-31 03934865 d:OrdinaryShareClass2 2025-03-31 03934865 d:OrdinaryShareClass2 2024-03-31 03934865 d:FRS102 2024-04-01 2025-03-31 03934865 d:Audited 2024-04-01 2025-03-31 03934865 d:FullAccounts 2024-04-01 2025-03-31 03934865 d:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 03934865 e:Subsidiary1 2024-04-01 2025-03-31 03934865 e:Subsidiary1 1 2024-04-01 2025-03-31 03934865 e:Subsidiary2 2024-04-01 2025-03-31 03934865 e:Subsidiary2 1 2024-04-01 2025-03-31 03934865 d:Consolidated 2025-03-31 03934865 d:ConsolidatedGroupCompanyAccounts 2024-04-01 2025-03-31 03934865 6 2024-04-01 2025-03-31 03934865 e:ShareCapital 2 2023-04-01 2024-03-31 03934865 e:ShareCapital 3 2023-04-01 2024-03-31 03934865 f:PoundSterling 2024-04-01 2025-03-31 iso4217:GBP xbrli:shares xbrli:pure

Registered number: 03934865










SAHARA CARE LIMITED










ANNUAL REPORT AND FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2025

 
SAHARA CARE LIMITED
 
 
COMPANY INFORMATION


Directors
T W Brown FCCA CTA FCG FAIA 
H S Kaur 
C B C Manhire BSc (Est Man) FRICS 
D  S Turner FCCA 
A P Betts 




Company secretary
D S Turner FCCA



Registered number
03934865



Registered office
14th Floor
33 Cavendish Square

London

W1G 0PW




Independent auditors
Sumer Auditco Limited

14th Floor

33 Cavendish Square

London

W1G 0PW





 
SAHARA CARE LIMITED
 

CONTENTS



Page
Group strategic report
1 - 2
Directors' report
3 - 4
Independent auditors' report
5 - 8
Consolidated statement of comprehensive income
9
Consolidated balance sheet
10
Company balance sheet
11 - 12
Consolidated statement of changes in equity
13
Company statement of changes in equity
14
Consolidated statement of cash flows
15
Consolidated analysis of net debt
16
Notes to the financial statements
17 - 34


 
SAHARA CARE LIMITED
 
 
GROUP STRATEGIC REPORT
FOR THE YEAR ENDED 31 MARCH 2025

Introduction
 
The board of directors are responsible for the Company’s approach to assessing risk and the senior leadership
team is responsible for managing risk and maintaining appropriate controls on a day-to-day basis.

Business review
 
For the year ended 31 March 2025, total revenue increased by 9.4% whilst direct costs increase by 7.4%, resulting in an increase in gross profits of 13.9%.
Our service users continue to be at the centre of the organisation’s strategic objectives. Our aim remains to provide a pathway to positive outcomes for each and every one of them, where they can take control of their life and the decisions that shape it.
Despite the continuation of cost challenges that we and the sector as a whole face, we have been able to manage cost increases by balancing these against inflationary fee increases and eliminating the usage of agency workers. Our occupancy increased 8% from the previous year, and this continues to be our focus.  

Results & performance

The results of the group for the year, as set out on page 9, disclose a profit before taxation of £796,867 (2024 £761,462). The shareholders’ funds of the group total £8,591,580 (2024 - £8,144,359).
At the date of reporting the group were operating 4 registered care homes with a total of 63 registered beds.
At the date of reporting the group had a bank loan of £128,875 (2024 - £366,850). The group has no other external borrowings and the bank loan was fully settled after the year end.

Principal risks and uncertainties
 
The management and staff of the company are primarily focused on the needs and dignity of the people we support. Standards of care are constantly assessed by a comprehensive internal audit process. Our Service managers are responsible for achieving full compliance within the Care Quality Commission’s Key Lines of Enquiry (KLOEs). The Nominated Individual managing our homes is Alan Betts who has many years’ experience, managing care homes and the board are confident his skills and experience will prove invaluable in taking Sahara successfully into the future.
The company has been well placed to weather the financial storms that have engulfed the care sector, although the recent changes imposed upon the sector by the Government in its October 2024 Budget had not been anticipated by the Company nor the care sector. Financial difficulties are normally caused by failure to meet bank interest, capital repayments, and/or increasing rents. Fortunately, the company has a low level of bank debt and owns the freeholds of its homes and constantly monitors its cashflow position. Local Authority support has been important and so too has the support received from our local CCGs, NHS, relatives, and service users, and we thank them all.
The company strives to be the employer of choice, providing high quality training to employees and implementing appraisal systems, encouraging feedback and development opportunities. We expect and require all staff to conduct themselves in accordance with the highest ethical standards. Employees and all applicants for employment are regarded equally and are given equal opportunities irrespective of their race, colour, nationality, religion, sex, sexual orientation, marital status, age, disability, or ethnic origin. The company provides life cover for employees amounting to three times their annual gross salary.

Page 1

 
SAHARA CARE LIMITED
 

GROUP STRATEGIC REPORT (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025

Financial key performance indicators
 
The group produces a monthly accounting pack together with detailed management reports, these reports include several key performance indicators (KPIs) which are a fundamental part of this process.
The reports focus on the actual performance of the business compared with the budget set for the current financial period, and results from prior financial years. The KPIs that form part of the review process include payroll costs to turnover, actual support hours given to commissioned hours, operating profit and EBITDA.
The Directors work closely with the Senior Management Team (SMT) to diligently monitor both financial and non-financial KPIs, together with any potential risks to the business. This is in part undertaken through in-depth monthly SMT and board meetings. Each home also undertakes several weekly and monthly meetings, with their staff, to ensure all areas of the business and our service are carefully monitored and managed.
Non-financial KPIs include occupancy as a percentage of available beds, training statistics, internal quality of care audits and health and safety scores.  
Occupancy as a percentage of available beds for the year ended 31st March 2025 increased, illustrating the demand for the type of high-quality care that we provide. 

Other key performance indicators
 
From an operational viewpoint the KPIs have helped identify where fees are being suppressed by local authorities against a backdrop of ever-increasing compliance costs. We continue to work closely with the relevant local authorities to maintain and improve the high standard of care that we strive to provide, and this close working relationship enables us to address any issues and fee discrepancies that may arise. 


This report was approved by the board on 25 November 2025 and signed on its behalf.



T W Brown FCCA CTA FCG FAIA
Director

Page 2

 
SAHARA CARE LIMITED
 
 
 
DIRECTORS' REPORT
FOR THE YEAR ENDED 31 MARCH 2025

The directors present their report and the financial statements for the year ended 31 March 2025.

Directors' responsibilities statement

The directors are responsible for preparing the Group strategic report, the Directors' report and the consolidated financial statements in accordance with applicable law and regulations.
 
Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice), including Financial Reporting Standard 102 ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland'. Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the Company and the Group and of the profit or loss of the Group for that period.

 In preparing these financial statements, the directors are required to:


select suitable accounting policies for the Group's financial statements and then apply them consistently;

make judgments and accounting estimates that are reasonable and prudent;

prepare the financial statements on the going concern basis unless it is inappropriate to presume that the Group will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the Company's transactions and disclose with reasonable accuracy at any time the financial position of the Company and the Group and to enable them to ensure that the financial statements comply with the Companies Act 2006They are also responsible for safeguarding the assets of the Company and the Group and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Principal activity

The principal activity of the company is the provision of care services.

Results and dividends

The profit for the year, after taxation, amounted to £597,221 (2024 - £611,399).

Dividends of £Nil (2024: £2,000) were paid on Ordinary shares and £150,000 (2024: £150,000) on
preference shares.
The directors have highlighted in the strategic report on pages 1-2, a review of the current year results, future
outlook expectations, risks and key performance indicators for the group.

Directors

The directors who served during the year were:

T W Brown FCCA CTA FCG FAIA 
H S Kaur 
C B C Manhire BSc (Est Man) FRICS 
D  S Turner FCCA 
A P Betts 

Page 3

 
SAHARA CARE LIMITED
 
 
 
DIRECTORS' REPORT (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025

Future developments

There are no likely significant future developments in the business which require disclosure.

Disclosure of information to auditors

Each of the persons who are directors at the time when this Directors' report is approved has confirmed that:
 
so far as the director is aware, there is no relevant audit information of which the Company and the Group's auditors are unaware, and

the director has taken all the steps that ought to have been taken as a director in order to be aware of any relevant audit information and to establish that the Company and the Group's auditors are aware of that information.

Post balance sheet events

There have been no significant events affecting the Group since the year end.

Auditors

The auditorsSumer Auditco Limitedwill be proposed for reappointment in accordance with section 485 of the Companies Act 2006.

This report was approved by the board on 25 November 2025 and signed on its behalf.
 





T W Brown FCCA CTA FCG FAIA
Director

Page 4

 
SAHARA CARE LIMITED
 
 
 
INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF SAHARA CARE LIMITED
 

Opinion


We have audited the financial statements of Sahara Care Limited (the 'parent Company') and its subsidiaries (the 'Group') for the year ended 31 March 2025, which comprise the Consolidated statement of comprehensive income, the Consolidated balance sheet, the Company balance sheet, the Consolidated statement of cash flows, the Consolidated statement of changes in equity, the Company statement of changes in equity and the related notes, including a summary of significant accounting policiesThe financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).


In our opinion the financial statements:


give a true and fair view of the state of the Group's and of the parent Company's affairs as at 31 March 2025 and of the Group's profit for the year then ended;
have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
have been prepared in accordance with the requirements of the Companies Act 2006.


Basis for opinion


We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the Group in accordance with the ethical requirements that are relevant to our audit of the financial statements in the United Kingdom, including the Financial Reporting Council's Ethical Standard and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.


Conclusions relating to going concern


In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.


Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the Group's or the parent Company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.


Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.


Page 5

 
SAHARA CARE LIMITED
 
 
 
INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF SAHARA CARE LIMITED (CONTINUED)


Other information


The other information comprises the information included in the Annual Report other than the financial statements and our Auditors' report thereon. The directors are responsible for the other information contained within the Annual ReportOur opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.


We have nothing to report in this regard.


Opinion on other matters prescribed by the Companies Act 2006
 

In our opinion, based on the work undertaken in the course of the audit:


the information given in the Group strategic report and the Directors' report for the financial year for which the financial statements are prepared is consistent with the financial statements; and
the Group strategic report and the Directors' report have been prepared in accordance with applicable legal requirements.


Matters on which we are required to report by exception
 

In the light of the knowledge and understanding of the Group and the parent Company and its environment obtained in the course of the audit, we have not identified material misstatements in the Group strategic report or the Directors' report.


We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:


adequate accounting records have not been kept by the parent Company, or returns adequate for our audit have not been received from branches not visited by us; or
the parent Company financial statements are not in agreement with the accounting records and returns; or
certain disclosures of directors' remuneration specified by law are not made; or
we have not received all the information and explanations we require for our audit.


Responsibilities of directors
 

As explained more fully in the Directors' responsibilities statement set out on page 3, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.


In preparing the financial statements, the directors are responsible for assessing the Group's and the parent Company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the Group or the parent Company or to cease operations, or have no realistic alternative but to do so.


Page 6

 
SAHARA CARE LIMITED
 
 
 
INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF SAHARA CARE LIMITED (CONTINUED)


Auditors' responsibilities for the audit of the financial statements
 

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an Auditors' report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these Group financial statements.


Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

In order to identify and assess the risks of material misstatements, including fraud and non-compliance with
laws and regulations that could be expected to have a material impact on the financial statements, we have
considered:
•  the results of our enquiries of management and those charged with governance of their assessment of
 the risks of fraud and irregularities;
•  the nature of the company, including its management structure and control systems (including the
 opportunity for management to override such controls);and
•  the industry and environment in which it operates.
We also considered UK tax and pension legislation and laws and regulations relating to employment and the
preparation and presentation of the financial statements such as the Companies Act 2006.
Based on this understanding we identified the following matters as being of significance to the entity:
•  laws and regulations considered to have a direct effect on the financial statements including UK financial
 reporting standards, Company Law, tax and pension legislation;
•  the timing of the recognition of commercial income;
•  compliance with legislation relating to health and safety and environmental legislation;
•  management bias in selecting accounting policies and determining estimates;
•  inappropriate journal entries; and
•  recoverability of debtors.
We communicated the outcomes of these discussions and enquiries, as well as consideration as to where and
how fraud may occur in the entity, to all engagement team members.
Audit procedures undertaken in response to the potential risks relating to irregularities (which include fraud and
non-compliance with laws and regulations) comprised:
•  enquiries of management and those charged with governance as to whether the entity complies with such
 laws and regulations; and discussion with the same regarding any known or suspected instances of non-   compliance or fraud;
•  enquiries with the same concerning any actual or potential litigation or claims;
•  review documentation relating to compliance with the regulations, including review of CQC reports;
•  inspection of relevant legal correspondence;
•  assessment of matters reported to management and the result of the subsequent investigation;
•  obtaining an understanding of the relevant controls during the period;
•  obtaining an understanding of the policies and controls over the recognition of income and testing their
 implementation during the year;
•  challenging assumptions made by management in their specific accounting policies and estimates;
•  identifying and testing journal entries, in particular any journal entries posted with unusual account
 
Page 7

 
SAHARA CARE LIMITED
 
 
 
INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF SAHARA CARE LIMITED (CONTINUED)


 combinations or crediting revenue or cash;
•  assessing the recovery of debtors in the period since the balance sheet date and challenging
 assumptions made by management regarding the recovery of balances which remain outstanding;
•  reviewing the financial statements for compliance with the relevant disclosure requirements;
•  performing analytical procedures to identify any unusual or unexpected relationships or unexpected
 movements in account balances which may be indicative of fraud; and
•  reviewing the minutes of Board meetings and correspondence with HMRC.
No instances of material non-compliance were identified. However, the likelihood of detecting irregularities,
including fraud, is limited by the inherent difficulty in detecting irregularities, the effectiveness of the entity’s
controls, and the nature, timing and extent of the audit procedures performed. Irregularities that result from
fraud might be inherently more difficult to detect than irregularities that result from error. As explained above,
there is an unavoidable risk that material misstatements may not be detected, even though the audit has been
planned and performed in accordance with ISAs (UK).


A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at: www.frc.org.uk/auditorsresponsibilities. This description forms part of our Auditors' report.


Use of our report
 

This report is made solely to the Company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006Our audit work has been undertaken so that we might state to the Company's members those matters we are required to state to them in an Auditors' report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the Company and the Company's members, as a body, for our audit work, for this report, or for the opinions we have formed.





David Pumfrey FCA (Senior statutory auditor)
  
for and on behalf of
Sumer Auditco Limited
 
Statutory Auditors
  
14th Floor
33 Cavendish Square
London
W1G 0PW

25 November 2025
Page 8

 
SAHARA CARE LIMITED
 
 
CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 MARCH 2025

2025
2024
Note
£
£

  

Turnover
 4 
5,488,864
5,016,599

Cost of sales
  
(3,736,333)
(3,477,818)

Gross profit
  
1,752,531
1,538,781

Administrative expenses
  
(932,230)
(997,777)

Other operating income
 5 
-
19,134

Fair value movements
  
-
231,893

Operating profit
 6 
820,301
792,031

Interest payable and similar expenses
 10 
(23,434)
(30,569)

Profit before tax
  
796,867
761,462

Tax on profit
 11 
(199,646)
(150,063)

Profit for the financial year
  
597,221
611,399

Profit for the year attributable to:
  

Owners of the parent company
  
597,221
611,399

  
597,221
611,399

There was no other comprehensive income for 2025 (2024:£NIL).

The notes on pages 17 to 34 form part of these financial statements.

Page 9

 
SAHARA CARE LIMITED
REGISTERED NUMBER: 03934865

CONSOLIDATED BALANCE SHEET
AS AT 31 MARCH 2025

2025
2024
Note
£
£

Fixed assets
  

Tangible assets
 15 
8,687,458
8,707,930

  
8,687,458
8,707,930

Current assets
  

Debtors: amounts falling due within one year
 17 
221,889
345,619

Cash at bank and in hand
 18 
797,364
649,276

  
1,019,253
994,895

Creditors: amounts falling due within one year
 19 
(964,027)
(1,165,792)

Net current assets/(liabilities)
  
 
 
55,226
 
 
(170,897)

Total assets less current liabilities
  
8,742,684
8,537,033

Creditors: amounts falling due after more than one year
 20 
(30,198)
(268,173)

Provisions for liabilities
  

Deferred tax
 22 
(120,906)
(124,501)

  
 
 
(120,906)
 
 
(124,501)

Net assets
  
8,591,580
8,144,359


Capital and reserves
  

Called up share capital 
 23 
5,000,100
5,000,100

Revaluation reserve
 24 
477,658
477,658

Profit and loss account
 24 
3,113,822
2,666,601

  
8,591,580
8,144,359


The financial statements were approved and authorised for issue by the board and were signed on its behalf on 25 November 2025.




T W Brown FCCA CTA FCG FAIA
Director

The notes on pages 17 to 34 form part of these financial statements.

Page 10

 
SAHARA CARE LIMITED
REGISTERED NUMBER: 03934865

COMPANY BALANCE SHEET
AS AT 31 MARCH 2025

2025
2024
Note
£
£

Fixed assets
  

Tangible assets
 15 
4,371,600
4,387,802

Investments
 16 
204,182
204,182

  
4,575,782
4,591,984

Current assets
  

Debtors: amounts falling due after more than one year
 17 
2,865,984
3,279,824

Debtors: amounts falling due within one year
 17 
130,232
245,884

Cash at bank and in hand
 18 
767,238
634,481

  
3,763,454
4,160,189

Creditors: amounts falling due within one year
 19 
(659,977)
(864,841)

Net current assets
  
 
 
3,103,477
 
 
3,295,348

Total assets less current liabilities
  
7,679,259
7,887,332

  

Creditors: amounts falling due after more than one year
 20 
(30,198)
(268,173)

Provisions for liabilities
  

Deferred taxation
 22 
(120,906)
(124,501)

  
 
 
(120,906)
 
 
(124,501)

Net assets
  
7,528,155
7,494,658


Capital and reserves
  

Called up share capital 
 23 
5,000,100
5,000,100

Revaluation reserve
 24 
477,658
477,658

Profit and loss account
 24 
2,050,397
2,016,900

  
7,528,155
7,494,658


Page 11

 
SAHARA CARE LIMITED
REGISTERED NUMBER: 03934865
    
COMPANY BALANCE SHEET (CONTINUED)
AS AT 31 MARCH 2025

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 25 November 2025.


T W Brown FCCA CTA FCG FAIA
Director

The notes on pages 17 to 34 form part of these financial statements.

Page 12
 

 
SAHARA CARE LIMITED


 

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 MARCH 2025



Called up share capital
Revaluation reserve
Profit and loss account
Equity attributable to owners of parent Company
Total equity


£
£
£
£
£



At 1 April 2023
5,000,100
265,678
2,419,182
7,684,960
7,684,960



Comprehensive income for the year


Profit for the year
-
-
611,399
611,399
611,399


Dividends: Equity capital
-
-
(152,000)
(152,000)
(152,000)


Fair value movement on Investment property
-
231,893
(231,893)
-
-


Deferred tax movement on Investment property
-
(19,913)
19,913
-
-





At 1 April 2024
5,000,100
477,658
2,666,601
8,144,359
8,144,359



Comprehensive income for the year


Profit for the year
-
-
597,221
597,221
597,221


Dividends: Equity capital
-
-
(150,000)
(150,000)
(150,000)



At 31 March 2025
5,000,100
477,658
3,113,822
8,591,580
8,591,580



The notes on pages 17 to 34 form part of these financial statements.

Page 13

 

 
SAHARA CARE LIMITED


 

COMPANY STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 MARCH 2025



Called up share capital
Revaluation reserve
Profit and loss account
Total equity


£
£
£
£



At 1 April 2023
5,000,100
265,678
2,068,738
7,334,516



Comprehensive income for the year


Profit for the year
-
-
312,142
312,142


Dividends: Equity capital
-
-
(152,000)
(152,000)


Fair value movement on Investment property
-
231,893
(231,893)
-


Deferred tax movement on Investment property
-
(19,913)
19,913
-





At 1 April 2024
5,000,100
477,658
2,016,900
7,494,658



Comprehensive income for the year


Profit for the year
-
-
183,497
183,497


Dividends: Equity capital
-
-
(150,000)
(150,000)



At 31 March 2025
5,000,100
477,658
2,050,397
7,528,155



The notes on pages 17 to 34 form part of these financial statements.

Page 14
 
SAHARA CARE LIMITED
 

CONSOLIDATED STATEMENT OF CASH FLOWS
FOR THE YEAR ENDED 31 MARCH 2025

2025
2024
£
£

Cash flows from operating activities

Profit for the financial year
597,221
611,399

Adjustments for:

Depreciation of tangible assets
34,387
48,422

Loss on disposal of tangible assets
-
484

Government grants
-
(10,000)

Interest paid
23,434
30,569

Taxation charge
199,646
150,063

Decrease in debtors
123,730
150,332

(Decrease) in creditors
(154,913)
(37,875)

Net fair value losses/(gains) recognised in P&L
-
(231,893)

Corporation tax (paid)
(249,366)
(82,459)

Net cash generated from operating activities

574,139
629,042


Cash flows from investing activities

Purchase of tangible fixed assets
(13,915)
(17,459)

Sale of tangible fixed assets
-
325

Government grants received
-
10,000

Net cash from investing activities

(13,915)
(7,134)

Cash flows from financing activities

Repayment of bank loans
(237,975)
(80,914)

Repayment of other loans
-
(17,200)

Dividends paid
(150,000)
(152,000)

Interest paid
(24,161)
(30,569)

Net cash used in financing activities
(412,136)
(280,683)

Net increase in cash and cash equivalents
148,088
341,225

Cash and cash equivalents at beginning of year
649,276
308,051

Cash and cash equivalents at the end of year
797,364
649,276


Cash and cash equivalents at the end of year comprise:

Cash at bank and in hand
797,364
649,276

797,364
649,276


Page 15

 
SAHARA CARE LIMITED
 

CONSOLIDATED ANALYSIS OF NET DEBT
FOR THE YEAR ENDED 31 MARCH 2025





At 1 April 2024
Cash flows
Other non-cash changes
At 31 March 2025
£

£

£

£

Cash at bank and in hand

649,276

148,088

-

797,364

Debt due after 1 year

(268,173)

139,298

98,677

(30,198)

Debt due within 1 year

(142,411)

83,067

(98,677)

(158,021)


238,692
370,453
-
609,145

The notes on pages 17 to 34 form part of these financial statements.

Page 16

 
SAHARA CARE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

1.


General information

The company is a private company limited by shares, and is incorporated in England & Wales. The
address of its registered office is 14th Floor, 33 Cavendish Square, London, W1G 0PW. The principal activity of the company is the provision of residential care services.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The preparation of financial statements in compliance with FRS 102 requires the use of certain critical accounting estimates. It also requires Group management to exercise judgment in applying the Group's accounting policies (see note 3).

The Company has taken advantage of the exemption allowed under section 408 of the Companies Act 2006 and has not presented its own Statement of comprehensive income in these financial statements.

The following principal accounting policies have been applied:

 
2.2

Basis of consolidation

The consolidated financial statements present the results of the Company and its own subsidiaries ("the Group") as if they form a single entity. Intercompany transactions and balances between group companies are therefore eliminated in full.
The consolidated financial statements incorporate the results of business combinations using the purchase method. In the Balance sheet, the acquiree's identifiable assets, liabilities and contingent liabilities are initially recognised at their fair values at the acquisition date. The results of acquired operations are included in the Consolidated statement of comprehensive income from the date on which control is obtained. They are deconsolidated from the date control ceases.
In accordance with the transitional exemption available in FRS 102, the Group has chosen not to retrospectively apply the standard to business combinations that occurred before the date of transition to FRS 102, being 01 April 2015.

Page 17

 
SAHARA CARE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

2.Accounting policies (continued)

 
2.3

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Group and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Group will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

Revenue represents fees receivable for the provision of care services.

 
2.4

Government grants

Grants are accounted under the accruals model as permitted by FRS 102. Grants relating to expenditure on tangible fixed assets are credited to profit or loss at the same rate as the depreciation on the assets to which the grant relates. The deferred element of grants is included in creditors as deferred income.
Grants of a revenue nature are recognised in the Consolidated statement of comprehensive income in the same period as the related expenditure.

 
2.5

Finance costs

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

 
2.6

Borrowing costs

All borrowing costs are recognised in profit or loss in the year in which they are incurred.

Page 18

 
SAHARA CARE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

2.Accounting policies (continued)

 
2.7

Pensions

Defined contribution pension plan

The Group operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Group pays fixed contributions into a separate entity. Once the contributions have been paid the Group has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Balance sheet. The assets of the plan are held separately from the Group in independently administered funds.

 
2.8

Current and deferred taxation

The tax expense for the year comprises current and deferred tax. Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company and the Group operate and generate income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the balance sheet date, except that:
The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits;
Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met; and
Where they relate to timing differences in respect of interests in subsidiaries, associates, branches and joint ventures and the Group can control the reversal of the timing differences and such reversal is not considered probable in the foreseeable future.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


 
2.9

Intangible assets

Intangible assets are initially recognised at cost. After recognition, under the cost model, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

All intangible assets are considered to have a finite useful life. If a reliable estimate of the useful life cannot be made, the useful life shall not exceed ten years.

Page 19

 
SAHARA CARE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

2.Accounting policies (continued)

 
2.10

Development costs

Enter user text here... 

 
2.11

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Freehold property
-
Not depreciated
Motor vehicles
-
25%
Reducing balance method
Computer equipment
-
25%
Other fixed assets
-
25%

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

The directors are of the opinion that the residual value of freehold buildings, at the end of their
estimated useful economic life, will exceed book value and hence no depreciation is provided.

 
2.12

Valuation of investments

Investments in subsidiaries are measured at cost less accumulated impairment.

 
2.13

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.14

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

In the Consolidated statement of cash flows, cash and cash equivalents are shown net of bank overdrafts that are repayable on demand and form an integral part of the Group's cash management.

Page 20

 
SAHARA CARE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

2.Accounting policies (continued)

 
2.15

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.16

Provisions for liabilities

Provisions are recognised when an event has taken place that gives rise to a legal or constructive obligation, a transfer of economic benefits is probable and a reliable estimate can be made.
Provisions are measured as the best estimate of the amount required to settle the obligation, taking into account the related risks and uncertainties.
 
Increases in provisions are generally charged as an expense to profit or loss.

 
2.17

Financial instruments

The Group has elected to apply the provisions of Section 11 “Basic Financial Instruments” of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the Group's Balance sheet when the Group becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include trade and other debtors, cash and bank balances, are initially measured at their transaction price (adjusted for transaction costs except in the initial measurement of financial assets that are subsequently measured at fair value through profit and loss) and are subsequently carried at their amortised cost using the effective interest method, less any provision for impairment, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Discounting is omitted where the effect of discounting is immaterial. The Group's cash and cash equivalents, trade and most other debtors due with the operating cycle fall into this category of financial instruments.

Basic financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Group after the deduction of all its liabilities.

Basic financial liabilities, which include trade and other creditors, bank loans, other loans and loans due to fellow group companies are initially measured at their transaction price (adjusting for transaction costs except in the initial measurement of financial liabilities that are subsequently measured at fair value through profit and loss). When this constitutes a financing transaction, whereby the debt instrument is measured at the present value of the future payments discounted at a market rate of interest, discounting is omitted where the effect of discounting is immaterial.
Page 21

 
SAHARA CARE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

2.Accounting policies (continued)


2.17
Financial instruments (continued)


Debt instruments are subsequently carried at their amortised cost using the effective interest rate method.

Trade creditors are obligations to pay for goods and services that have been acquired in the ordinary course of business from suppliers. Trade creditors are classified as current liabilities if the payment is due within one year. If not, they represent non-current liabilities. Trade creditors are initially recognised at their transaction price and subsequently are measured at amortised cost using the effective interest method. Discounting is omitted where the effect of discounting is immaterial.

Derecognition of financial instruments

Derecognition of financial assets

Financial assets are derecognised when their contractual right to future cash flow expire, or are settled, or when the Group transfers the asset and substantially all the risks and rewards of ownership to another party. If significant risks and rewards of ownership are retained after the transfer to another party, then the Group will continue to recognise the value of the portion of the risks and rewards retained.

Derecognition of financial liabilities

Financial liabilities are derecognised when the Group's contractual obligations expire or are discharged or cancelled.

 
2.18

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.


3.


Judgments in applying accounting policies and key sources of estimation uncertainty

Estimates and judgements are continually evaluated and are based on historical experience and other
factors, including expectations of future events that are believed to be reasonable under the
circumstances.
The company makes estimates and assumptions concerning the future. Actual results may differ from
these estimates. Revisions to accounting estimates are recognised in the period in which the estimate is
revised where the revision affects only that period, or in the period of the revision and future periods
where the revision affects both current and future periods.

Page 22

 
SAHARA CARE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

4.


Turnover

An analysis of turnover by class of business is as follows:


2025
2024
£
£

Residential care fees receivable
5,455,404
4,978,980

Rent receivable
33,460
37,619

5,488,864
5,016,599


All turnover arose within the United Kingdom.


5.


Other operating income

2025
2024
£
£

Government grants receivable
-
19,134



6.


Operating profit

The operating profit is stated after charging:

2025
2024
£
£

Depreciation
34,387
48,422


7.


Auditors' remuneration

During the year, the Group obtained the following services from the Company's auditors:


2025
2024
£
£

Fees payable to the Company's auditors for the audit of the consolidated and parent Company's financial statements
23,625
22,500

Page 23

 
SAHARA CARE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

8.


Employees

Staff costs, including directors' remuneration, were as follows:


Group
Group
Company
Company
2025
2024
2025
2024
£
£
£
£


Wages and salaries
3,540,679
3,232,291
1,834,060
1,806,674

Social security costs
321,632
287,947
168,526
164,565

Cost of defined contribution scheme
108,187
113,075
57,386
61,605

3,970,498
3,633,313
2,059,972
2,032,844


The average monthly number of employees, including the directors, during the year was as follows:



Group
Group
Company
Company
        2025
        2024
        2025
        2024
            No.
            No.
            No.
            No.









Administration
8
8
8
8



Support Providers
127
121
66
65

135
129
74
73


9.


Directors' remuneration

2025
2024
£
£

Directors' emoluments
330,385
297,610

Group contributions to defined contribution pension schemes
10,863
21,823

341,248
319,433


During the year retirement benefits were accruing to 2 directors (2024 - 2) in respect of defined contribution pension schemes.

The highest paid director received remuneration of £255,738 (2024 - £239,526).

The value of the Group's contributions paid to a defined contribution pension scheme in respect of the highest paid director amounted to £10,000 (2024 - £10,000).

Page 24

 
SAHARA CARE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

10.


Interest payable and similar expenses

2025
2024
£
£


Bank interest payable
23,434
30,569


11.


Taxation


2025
2024
£
£

Corporation tax


Current tax on profits for the year
203,241
135,012

Adjustments in respect of previous periods
-
858


Total current tax
203,241
135,870

Deferred tax


Origination and reversal of timing differences
(3,595)
14,193

Total deferred tax
(3,595)
14,193


199,646
150,063
Page 25

 
SAHARA CARE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
 
11.Taxation (continued)


Factors affecting tax charge for the year

The tax assessed for the year is higher than (2024 - lower than) the standard rate of corporation tax in the UK of 25% (2024 - 25%). The differences are explained below:

2025
2024
£
£


Profit on ordinary activities before tax
796,867
761,462


Profit on ordinary activities multiplied by standard rate of corporation tax in the UK of 25% (2024 - 25%)
199,217
190,366

Effects of:


Expenses not deductible for tax purposes, other than goodwill amortisation and impairment
1,354
461

Capital allowances for year in excess of depreciation
(4,828)
(5,187)

Adjustments to tax charge in respect of prior periods
-
858

Increase or decrease in pension fund creditor leading to an increase (decrease) in tax
3,903
1,504

Timing differences on fair value movements leading to an increase (decrease) in taxation
-
19,913

Fair value movements not taxable
-
(57,973)

Book profit on chargeable assets
-
121

Total tax charge for the year
199,646
150,063


Factors that may affect future tax charges

There were no factors that may affect future tax charges.


12.


Dividends

2025
2024
£
£


Ordinary shares
-
2,000


Preference shares
150,000
150,000

150,000
152,000

Page 26

 
SAHARA CARE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

13.


Parent company profit for the year

The Company has taken advantage of the exemption allowed under section 408 of the Companies Act 2006 and has not presented its own Statement of comprehensive income in these financial statements. The profit after tax of the parent Company for the year was £183,497 (2024 - £312,142).


14.


Intangible assets

Group and Company





Goodwill

£



Cost


At 1 April 2024
337,890



At 31 March 2025

337,890



Amortisation


At 1 April 2024
337,890



At 31 March 2025

337,890



Net book value



At 31 March 2025
-



At 31 March 2024
-



Page 27

 
SAHARA CARE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

15.


Tangible fixed assets

Group






Freehold property
Motor vehicles
Computer equipment
Other fixed assets
Total

£
£
£
£
£



Cost or valuation


At 1 April 2024
8,546,083
66,136
76,661
2,061,701
10,750,581


Additions
-
-
9,438
4,477
13,915



At 31 March 2025

8,546,083
66,136
86,099
2,066,178
10,764,496



Depreciation


At 1 April 2024
-
48,136
55,012
1,939,503
2,042,651


Charge for the year on owned assets
-
4,543
10,543
19,301
34,387



At 31 March 2025

-
52,679
65,555
1,958,804
2,077,038



Net book value



At 31 March 2025
8,546,083
13,457
20,544
107,374
8,687,458



At 31 March 2024
8,546,083
18,000
21,649
122,198
8,707,930




The net book value of land and buildings may be further analysed as follows:


2025
2024
£
£

Freehold
8,546,083
8,546,083


Page 28

 
SAHARA CARE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

           15.Tangible fixed assets (continued)


Company






Freehold property
Motor vehicles
Computer equipment
Other fixed assets
Total

£
£
£
£
£

Cost or valuation


At 1 April 2024
4,310,895
65,535
50,333
738,957
5,165,720


Additions
-
-
7,428
-
7,428



At 31 March 2025

4,310,895
65,535
57,761
738,957
5,173,148



Depreciation


At 1 April 2024
-
47,361
36,068
694,489
777,918


Charge for the year on owned assets
-
4,543
7,506
11,581
23,630



At 31 March 2025

-
51,904
43,574
706,070
801,548



Net book value



At 31 March 2025
4,310,895
13,631
14,187
32,887
4,371,600



At 31 March 2024
4,310,895
18,174
14,265
44,468
4,387,802





The net book value of land and buildings may be further analysed as follows:


2025
2024
£
£

Freehold
4,310,895
4,310,895


Page 29

 
SAHARA CARE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

16.


Fixed asset investments

Company





Investments in subsidiary companies

£



Cost


At 1 April 2024
204,182



At 31 March 2025
204,182





Subsidiary undertakings


The following were subsidiary undertakings of the Company:

Name

Principal activity

Class of shares

Holding

Sahara Parkside Limited
Residential care services
Ordinary
100%
Sahara Care Homes Limited
Dormant
Ordinary 'A'
100%

The registered office of both subsidiaries is the same as the parent company.

Page 30

 
SAHARA CARE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

17.


Debtors

Group
Group
Company
Company
2025
2024
2025
2024
£
£
£
£

Due after more than one year

Amounts owed by group undertakings
-
-
2,865,984
3,279,824


Group
Group
Company
Company
2025
2024
2025
2024
£
£
£
£

Due within one year

Trade debtors
89,382
290,220
30,212
196,735

Other debtors
5,339
8,262
4,879
7,741

Prepayments and accrued income
127,168
47,137
95,141
41,408

221,889
345,619
130,232
245,884



18.


Cash and cash equivalents

Group
Group
Company
Company
2025
2024
2025
2024
£
£
£
£

Cash at bank and in hand
797,364
649,276
767,238
634,481



19.


Creditors: Amounts falling due within one year

Group
Group
Company
Company
2025
2024
2025
2024
£
£
£
£

Bank loans
98,677
98,677
98,677
98,677

Other loans
15,000
15,000
-
-

Trade creditors
226,256
324,820
171,827
294,729

Corporation tax
88,706
134,831
25,095
41,606

Other taxation and social security
82,476
68,500
50,636
40,425

Other creditors
329,491
321,991
209,795
207,704

Accruals and deferred income
123,421
201,973
103,947
181,700

964,027
1,165,792
659,977
864,841


For detail of bank loan security, see note 20.

Page 31

 
SAHARA CARE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

20.


Creditors: Amounts falling due after more than one year

Group
Group
Company
Company
2025
2024
2025
2024
£
£
£
£

Bank loans
30,198
268,173
30,198
268,173


The bank loans are secured against a debenture over the assets of the group and by way of a mortgage
over specific assets of the group.


21.


Loans


Analysis of the maturity of loans is given below:


Group
Group
Company
Company
2025
2024
2025
2024
£
£
£
£

Amounts falling due within one year

Bank loans
98,677
98,677
98,677
98,677

Other loans
15,000
15,000
-
-


113,677
113,677
98,677
98,677

Amounts falling due 1-2 years

Bank loans
30,198
98,677
30,198
98,677

Amounts falling due 2-5 years

Bank loans
-
169,496
-
169,496


143,875
381,850
128,875
366,850


Page 32

 
SAHARA CARE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

22.


Deferred taxation


Group



2025
2024


£

£






At beginning of year
124,501
110,308


Charged to profit or loss
(3,595)
14,193



At end of year
120,906
124,501

Company


2025
2024


£

£






At beginning of year
124,501
110,308


Charged to profit or loss
(3,595)
14,193



At end of year
120,906
124,501

Group
Group
Company
Company
2025
2024
2025
2024
£
£
£
£

Accelerated capital allowances
12,438
16,033
12,438
16,033

Fair value movements
108,468
108,468
108,468
108,468

120,906
124,501
120,906
124,501


23.


Share capital

2025
2024
£
£
Allotted, called up and fully paid



100 (2024 - 100) Ordinary shares of £1.00 each
100
100
5,000,000 (2024 - 5,000,000) Preference shares of £1.00 each
5,000,000
5,000,000

5,000,100

5,000,100

There is a single class of Ordinary shares. Preference shares accrue a fixed cumulative preferential dividend at the annual rate of 3% of the issue price.


Page 33

 
SAHARA CARE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

24.


Reserves

Revaluation reserve

This comprises the historic accumulated movements in the fair value of Investment Property and associated Deferred Tax provision, transferred to Tangible Fixed Assets using fair value at the date of transfer as deemed cost under FRS 102 16.9A.

Profit and loss account

This comprises accumulated profits available for distribution


25.


Pension commitments

The group operates a defined contributions pension scheme. The assets of the scheme are held separately from those of the group  in an independently administered fund. The pension cost charge represents contributions payable by the group  to the fund and amounted to £108,187 (2024 - £113,075). Contributions totalling £44,344 (2024 - £28,734) were payable to the fund at the balance sheet date and are included in creditors.


26.


Related party transactions

Group and Company
The Company has taken advantage of the exemption in FRS 102, paragraph 33.1.A "Related party
disclosures" whereby it has not disclosed transactions with any wholly owned subsidiary undertakings.
During the year, dividends of £150,000 (2024 - £150,000) were paid to the directors by the Company.
Included in other creditors at the balance sheet date is an amount of £37 (2024 - £14,511) owed to the directors.
All key management personnel are directors.


27.


Controlling party

There is no ultimate controlling party.

 
Page 34